Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3547 studies found for:    adult stem cell transplants | Interventional Studies
Show Display Options
Download search resultsDownload the search results for:
adult stem cell transplants | Interventional Studies (3547 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed
Has Results
Standard vs High-Dose Trivalent Inactivated Flu Vaccine in Adult Hematopoetic Stem Cell Transplant (HSCT) Recipients
Condition: Adult Stem Cell Hematopoetic Transplant
Interventions: Biological: High-Dose Trivalent Inactivated Influenza Vaccine (HD-TIV);   Biological: Standard Dose Trivalent Inactivated Flu Vaccine
2 Recruiting Maraviroc as GVHD Prophylaxis in Transplant Recipients
Conditions: Diagnoses That Require Stem Cell Transplant;   Graft Versus Host Disease (GVHD)
Intervention: Drug: Maraviroc
3 Recruiting Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases
Conditions: Hereditary Corneal Dystrophy;   Keratoconus
Interventions: Procedure: Lipoaspiration;   Procedure: Transplantation
4 Recruiting Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.
Condition: Crohn's Disease
Intervention: Other: Hematopoietic stem cell transplantation
5 Completed Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders
Conditions: Allogeneic Stem Cell Transplant;   Leukemia;   Non-Hodgkins;   Lymphoblastic Lymphoma;   Myelodysplastic Syndrome;   Paroxysmal Nocturnal Hemoglobinuria (PNH)
Intervention: Drug: cytoreductive regimen followed by a CD34+E- selected allogeneic stem cell transplant
6 Recruiting Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
Condition: Veno-occlusive Disease
Interventions: Drug: Defibrotide;   Other: Best Supportive Care
7 Recruiting Autologous Stem Cell Transplantation for Crohn's Disease
Condition: Crohn's Disease
Intervention: Biological: autologous CD34-selected peripheral blood stem cells transplant
8 Completed T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
Condition: Head and Neck Cancer
Intervention: Biological: autologous EBV specific CTLs
9 Completed Umbilical Cord Blood Stem Cell Transplantation in Adults With Advanced Blood Disorders or Cancer
Condition: Hematologic Neoplasms
Intervention: Procedure: Stem Cell Transplantation
10 Recruiting Immunotherapy Following Reduced Intensity Conditioning and Allogeneic Stem Cell Transplant for Poor Risk CD30+ Hodgkin Lymphoma Patients
Condition: Hodgkin Lymphoma
Interventions: Drug: Brentuximab Vedotin;   Procedure: Allogeneic Stem Cell Transplantation;   Drug: Reduced Intensity Conditioning
11 Unknown  Stem Cells for Treating Critical Ischemia
Conditions: Critical Limb Ischemia;   Ischemic Ulcers
Intervention: Procedure: stem cells transplant
12 Active, not recruiting Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life
Condition: Effect of Individualized Nutrition on Quality of Life
Intervention: Dietary Supplement: Individualized Nutrition
13 Recruiting CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Conditions: Chronic Myeloid Leukemia (CML);   Acute Myelogenous Leukemia (AML);;   Myelodysplastic Syndrome (MDS);;   Juvenile Myelomonocytic Leukemia (JMML);;   Acute Lymphoblastic Leukemia (ALL);;   Lymphoma (Hodgkin's and Non-Hodgkin's)
Interventions: Device: CliniMACS CD34+ Reagent System;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Alemtuzumab;   Drug: Tacrolimus;   Drug: Melphalan;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Methylprednisolone
14 Active, not recruiting MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Condition: Cytomegalovirus Infections
Interventions: Drug: MK-8228;   Drug: Placebo
15 Completed Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload
Condition: Iron Overload
Intervention: Drug: deferasirox
16 Completed Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Intervention: Biological: Autologous CD34+ stem cells
17 Active, not recruiting Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML
Condition: Acute Myeloid Leukemia (AML)
Intervention: Biological: Hematopoietic stem cells from bone marrow or peripheral blood
18 Completed Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Stem Cell Transplantation, Hematopoietic
Interventions: Drug: TBI/CY/VP-16;   Drug: FA-TBI/CY/VP-16
19 Not yet recruiting Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Stem Cell Transplant Patients
Conditions: Blood And Marrow Transplantation;   Adult Respiratory Distress Syndrome
Interventions: Biological: Mesenchymal Stem Cells (MSCs);   Other: Placebo;   Other: Standard of Care Treatment
20 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.